{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T02:36:41Z","timestamp":1774492601861,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,25]]},"DOI":"10.7759\/cureus.25339","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T02:52:15Z","timestamp":1653533535000},"source":"Crossref","is-referenced-by-count":2,"title":["Recurrence of Autoimmune\u202fHepatitis\u202fAfter COVID-19\u202fVaccination"],"prefix":"10.7759","author":[{"given":"Jon Elliott D","family":"Brubaker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher L","family":"Casaccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J","family":"Brazeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.04.003","article-title":"Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?","volume":"75","author":"Bril F","year":"2021","unstructured":"Bril F, Al Diffalha S, Dean M, Fettig DM. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?. J Hepatol. 2021, 75:222-4. 10.1016\/j.jhep.2021.04.003","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.06.014","article-title":"Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine","volume":"75","author":"Clayton-Chubb D","year":"2021","unstructured":"Clayton-Chubb D, Schneider D, Freeman E, Kemp W, Roberts SK. Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine. J Hepatol. 2021, 75:1249-50. 10.1016\/j.jhep.2021.06.014","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102706","article-title":"Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: a novel clinical entity?","volume":"123","author":"Ghielmetti M","year":"2021","unstructured":"Ghielmetti M, Schaufelberger HD, Mieli-Vergani G, Cerny A, Dayer E, Vergani D, Terziroli Beretta-Piccoli B. Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: a novel clinical entity?. J Autoimmun. 2021, 123:102706. 10.1016\/j.jaut.2021.102706","journal-title":"J Autoimmun"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.07.005","article-title":"An unusual case of acute cholestatic hepatitis after m-RNABNT162b2 (Comirnaty) SARS-CoV-2 vaccine: coincidence, autoimmunity or drug-related liver injury","volume":"75","author":"Lodato F","year":"2021","unstructured":"Lodato F, Larocca A, D'Errico A, Cennamo V. An unusual case of acute cholestatic hepatitis after m-RNABNT162b2 (Comirnaty) SARS-CoV-2 vaccine: coincidence, autoimmunity or drug-related liver injury. J Hepatol. 2021, 75:1254-6. 10.1016\/j.jhep.2021.07.005","journal-title":"J Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.06.004","article-title":"Another case of autoimmune hepatitis after SARS-CoV-2 vaccination - still casualty?","volume":"75","author":"Londo\u00f1o MC","year":"2021","unstructured":"Londo\u00f1o MC, Gratac\u00f3s-Gin\u00e8s J, S\u00e1ez-Pe\u00f1ataro J. Another case of autoimmune hepatitis after SARS-CoV-2 vaccination - still casualty?. J Hepatol. 2021, 75:1248-9. 10.1016\/j.jhep.2021.06.004","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.06.044","article-title":"The mRNA COVID-19 vaccine - a rare trigger of autoimmune hepatitis?","volume":"75","author":"McShane C","year":"2021","unstructured":"McShane C, Kiat C, Rigby J, Crosbie \u00d3. The mRNA COVID-19 vaccine - a rare trigger of autoimmune hepatitis?. J Hepatol. 2021, 75:1252-4. 10.1016\/j.jhep.2021.06.044","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.038","article-title":"Autoimmune hepatitis following SARS-CoV-2 vaccine: may not be a casuality","volume":"75","author":"Rocco A","year":"2021","unstructured":"Rocco A, Sgamato C, Compare D, Nardone G. Autoimmune hepatitis following SARS-CoV-2 vaccine: may not be a casuality. J Hepatol. 2021, 75:728-9. 10.1016\/j.jhep.2021.05.038","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.06.009","article-title":"Autoimmune hepatitis following COVID-19 vaccination: true causality or mere association?","volume":"75","author":"Tan CK","year":"2021","unstructured":"Tan CK, Wong YJ, Wang LM, Ang TL, Kumar R. Autoimmune hepatitis following COVID-19 vaccination: true causality or mere association?. J Hepatol. 2021, 75:1250-2. 10.1016\/j.jhep.2021.06.009","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102710","article-title":"Autoimmune hepatitis triggered by SARS-CoV-2 vaccination","volume":"123","author":"Vuille-Lessard \u00c9","year":"2021","unstructured":"Vuille-Lessard \u00c9, Montani M, Bosch J, Semmo N. Autoimmune hepatitis triggered by SARS-CoV-2 vaccination. J Autoimmun. 2021, 123:102710. 10.1016\/j.jaut.2021.102710","journal-title":"J Autoimmun"},{"key":"ref10","article-title":"Autoimmune hepatitis","author":"Dienstag JL","year":"2018","unstructured":"Dienstag JL. Autoimmune hepatitis. Harrison's Principles of Internal Medicine. Jameson J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J (ed): McGraw Hill, New York, NY; 2018. 2396-9."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani A","year":"2020","unstructured":"Vojdani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol. 2020, 217:108480. 10.1016\/j.clim.2020.108480","journal-title":"Clin Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108665","article-title":"Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to \"potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases\"","volume":"224","author":"Talotta R","year":"2021","unstructured":"Talotta R. Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to \"potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases\". Clin Immunol. 2021, 224:108665. 10.1016\/j.clim.2021.108665","journal-title":"Clin Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/92665-recurrence-of-autoimmunehepatitisafter-covid-19vaccination","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:13Z","timestamp":1707507373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/92665-recurrence-of-autoimmunehepatitisafter-covid-19vaccination"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.25339","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,25]]}}}